Loading...
XSTOARCOMA
Market cap12mUSD
Dec 23, Last price  
10.55SEK
1D
-1.86%
1Q
-30.13%
Jan 2017
179.84%
IPO
-9.60%
Name

Arcoma AB

Chart & Performance

D1W1MN
XSTO:ARCOMA chart
P/E
54.25
P/S
0.85
EPS
0.19
Div Yield, %
0.00%
Shrs. gr., 5y
1.05%
Rev. gr., 5y
6.41%
Revenues
163m
+30.36%
147,661,334101,312,157130,434,000123,285,000102,081,00091,848,000119,470,000133,672,000117,417,000117,130,000125,046,000163,015,000
Net income
3m
+34.81%
-3,226,662-11,624,161914,000-6,449,000-11,646,000-9,820,000-1,586,0006,610,0001,365,000-7,473,0001,902,0002,564,000
CFO
19m
P
-10,267,844-11,822,783-828,000-4,948,000-4,666,000-8,910,00045,00011,100,0006,846,000-1,932,000-179,00019,160,000
Earnings
Apr 23, 2025

Profile

Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in Växjö, Sweden.
URL
https://www.arcoma.se/
IPO date
Nov 14, 2014
Employees
32
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
163,015
30.36%
125,046
6.76%
117,130
-0.24%
Cost of revenue
111,601
96,732
101,174
Unusual Expense (Income)
NOPBT
51,414
28,314
15,956
NOPBT Margin
31.54%
22.64%
13.62%
Operating Taxes
570
219
(1,441)
Tax Rate
1.11%
0.77%
NOPAT
50,844
28,095
17,397
Net income
2,564
34.81%
1,902
-125.45%
(7,473)
-647.47%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,164
2,791
BB yield
-1.16%
-1.66%
Debt
Debt current
1,946
21,219
14,796
Long-term debt
2,014
3,986
2,643
Deferred revenue
Other long-term liabilities
175
192
407
Net debt
(1,519)
15,067
12,129
Cash flow
Cash from operating activities
19,160
(179)
(1,932)
CAPEX
(4,169)
(4,188)
Cash from investing activities
(2,553)
(4,169)
(4,188)
Cash from financing activities
(21,219)
9,646
2,395
FCF
58,787
20,424
18,272
Balance
Cash
5,001
9,660
4,832
Long term investments
478
478
478
Excess cash
3,886
Stockholders' equity
44,912
42,130
40,293
Invested Capital
52,705
67,273
61,055
ROIC
84.76%
43.79%
27.93%
ROCE
97.55%
39.79%
26.13%
EV
Common stock shares outstanding
13,321
13,064
12,942
Price
7.95
3.52%
7.68
-40.92%
13.00
-40.91%
Market cap
105,898
5.55%
100,333
-40.37%
168,246
-39.92%
EV
104,379
115,400
180,375
EBITDA
53,003
34,911
22,078
EV/EBITDA
1.97
3.31
8.17
Interest
1,392
902
760
Interest/NOPBT
2.71%
3.19%
4.76%